Dynamic cross-talk analysis among TNF-R, TLR-4 and IL-1R signalings in TNFα-induced inflammatory responses

BMC Medical Genomics

Volumn 3, Issue , 2010, Pages

  Yang, Shih Kuang ^a   Wang, Yu Chao ^a   Chao, Chun Cheih ^a   Chuang, Yung Jen ^a   Lan, Chung Yu ^a   Chen, Bor Sen ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; AUTACOID;

ALGORITHM; ARTICLE; DISEASE COURSE; ENDOTHELIUM CELL; FEEDBACK SYSTEM; GENE EXPRESSION PROFILING; INFLAMMATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; STATISTICAL MODEL; STIMULUS RESPONSE; BIOLOGICAL MODEL; FACTUAL DATABASE; HUMAN; METABOLISM; PROTEIN BINDING; TIME;

DATABASES, FACTUAL; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION MEDIATORS; MODELS, BIOLOGICAL; PROTEIN BINDING; RECEPTOR CROSS-TALK; RECEPTORS, INTERLEUKIN-1; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TIME FACTORS; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77952488171     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-3-19     Document Type: Article

References (83)

1. Robustness from top to bottom. H Kitano, Nat Genet 2006 38 133 133 10.1038/ng0206-133
2. Discovering functions and revealing mechanisms at molecular level from biological networks. S Zhang G Jin XS Zhang L Chen, Proteomics 2007 7 2856 2869 10.1002/pmic.200700095 17703505
3. Systems biology of neutrophil differentiation and immune response. K Theilgaard-Monch BT Porse N Borregaard, Curr Opin Immunol 2006 18 54 60 10.1016/j.coi.2005.11.010 16343884
4. Genome-wide analysis of host responses to the Pseudomonas aeruginosa type III secretion system yields synergistic effects. JK Ichikawa SB English MC Wolfgang R Jackson AJ Butte S Lory, Cell Microbiol 2005 7 1635 1646 10.1111/j.1462-5822.2005.00581.x 16207250
5. Location of pathogenic bacteria during persistent infections: insights from an analysis using game theory. SM Eswarappa, PLoS One 2009 4 5383 10.1371/journal.pone.0005383 19401783
6. Dissecting innate immune responses with the tools of systems biology. KD Smith H Bolouri, Curr Opin Immunol 2005 17 49 54 10.1016/j.coi.2004.11.005 15653310
7. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. E Girardin GE Grau JM Dayer P Roux-Lombard PH Lambert, N Engl J Med 1988 319 397 400 3135497
8. Mechanisms of cytotoxicity, cytolysis, and growth stimulation by TNF. C Baglioni, Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine New York Raven Press, Beutler B, 1992 425 438
9. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. DT Felson JJ Anderson M Boers C Bombardier D Furst C Goldsmith LM Katz R Lightfoot Jr H Paulus V Strand,, et al. Arthritis Rheum 1995 38 727 735 10.1002/art.1780380602 7779114
10. Along a TNF-paved road from dead parasites in red cells to cerebral malaria, and beyond. IA Clark, Parasitology 2009 136 1457 1468 10.1017/S0031182009006088 19450376
11. Endothelial atheroprotective and anti-inflammatory mechanisms. BC Berk JI Abe W Min J Surapisitchat C Yan, Ann N Y Acad Sci 2001 947 93 109 discussion 109-111 11795313
12. TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. L Verstrepen T Bekaert TL Chau J Tavernier A Chariot R Beyaert, Cell Mol Life Sci 2008 65 2964 2978 10.1007/s00018-008-8064-8 18535784
13. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. JA Brockman DC Scherer TA McKinsey SM Hall X Qi WY Lee DW Ballard, Mol Cell Biol 1995 15 2809 2818 7739562
14. Positive and negative signaling components involved in TNFalpha-induced NF-kappaB activation. H Li X Lin, Cytokine 2008 41 1 8 10.1016/j.cyto.2007.09. 016 18068998
15. KEGG: Kyoto Encyclopedia of Genes and Genomes. H Ogata S Goto K Sato W Fujibuchi H Bono M Kanehisa, Nucleic Acids Res 1999 27 29 34 10.1093/nar/27.1.29 9847135
16. Human Protein Reference Database - 2009 update. TS Keshava Prasad R Goel K Kandasamy S Keerthikumar S Kumar S Mathivanan D Telikicherla R Raju B Shafreen A Venugopal,, et al. Nucleic Acids Res 2009 37 767 772 10.1093/nar/gkn892 18988627
17. BioGRID: a general repository for interaction datasets. C Stark BJ Breitkreutz T Reguly L Boucher A Breitkreutz M Tyers, Nucleic Acids Res 2006 34 535 539 10.1093/nar/gkj109 16381927
18. STRING 8 - a global view on proteins and their functional interactions in 630 organisms. LJ Jensen M Kuhn M Stark S Chaffron C Creevey J Muller T Doerks P Julien A Roth M Simonovic,, et al. Nucleic Acids Res 2009 37 412 416 10.1093/nar/gkn760 18940858
19. Signalling pathways of the TNF superfamily: a double-edged sword. BB Aggarwal, Nat Rev Immunol 2003 3 745 756 10.1038/nri1184 12949498
20. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. KJ Tracey A Cerami, Annu Rev Med 1994 45 491 503 10.1146/annurev.med.45.1.491 8198398
21. Beyond tumor necrosis factor receptor: TRADD signaling in toll-like receptors. NJ Chen II Chio WJ Lin G Duncan H Chau D Katz HL Huang KA Pike Z Hao YW Su,, et al. Proc Natl Acad Sci USA 2008 105 12429 12434 10.1073/pnas. 0806585105 18719121
22. Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. H Ji A Pettit K Ohmura A Ortiz-Lopez V Duchatelle C Degott E Gravallese D Mathis C Benoist, J Exp Med 2002 196 77 85 10.1084/jem.20020439 12093872
23. The negative regulation of Toll-like receptor and associated pathways. T Lang A Mansell, Immunol Cell Biol 2007 85 425 434 10.1038/sj.icb.7100094 17621314
24. Potent anti-inflammatory effects of low-dose proteasome inhibition in the vascular system. A Ludwig M Fechner N Wilck S Meiners N Grimbo G Baumann V Stangl K Stangl, J Mol Med 2009 87 793 802 10.1007/s00109-009-0469-9 19399470
25. A new look at the statistical model identification. H Akaike, Automatic Control, IEEE Transactions on 1974 19 716 723 10.1109/TAC.1974.1100705
26. Integrated cellular network of transcription regulations and protein-protein interactions. YC Wang BS Chen, BMC Systems Biology 2010 4 20 20211003
27. Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones. NA Turner RS Mughal P Warburton DJ O'Regan SG Ball KE Porter, Cardiovasc Res 2007 76 81 90 10.1016/j.cardiores.2007.06.003 17612514
28. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. SA Greenfeder P Nunes L Kwee M Labow RA Chizzonite G Ju, J Biol Chem 1995 270 13757 13765 10.1074/jbc.270.23.13757 7775431
29. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. H Wesche WJ Henzel W Shillinglaw S Li Z Cao, Immunity 1997 7 837 847 10.1016/S1074-7613(00)80402-1 9430229
30. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. R Medzhitov P Preston-Hurlburt E Kopp A Stadlen C Chen S Ghosh CA Janeway Jr, Mol Cell 1998 2 253 258 10.1016/S1097-2765(00)80136-7 9734363
31. A wave of nascent transcription on activated human genes. Y Wada Y Ohta M Xu S Tsutsumi T Minami K Inoue D Komura J Kitakami N Oshida A Papantonis,, et al. Proc Natl Acad Sci USA 2009 106 18357 18361 10.1073/pnas.0902573106 19826084
32. Cytoscape: a software environment for integrated models of biomolecular interaction networks. P Shannon A Markiel O Ozier NS Baliga JT Wang D Ramage N Amin B Schwikowski T Ideker, Genome Res 2003 13 2498 2504 10.1101/gr.1239303 14597658
33. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. H Hsu HB Shu MG Pan DV Goeddel, Cell 1996 84 299 308 10.1016/S0092-8674(00)80984-8 8565075
34. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. DF Legler O Micheau MA Doucey J Tschopp C Bron, Immunity 2003 18 655 664 10.1016/S1074-7613(03)00092-X 12753742
35. Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and protection from cell death. K Tada T Okazaki S Sakon T Kobarai K Kurosawa S Yamaoka H Hashimoto TW Mak H Yagita K Okumura,, et al. J Biol Chem 2001 276 36530 36534 10.1074/jbc.M104837200 11479302
36. The essential role of MEKK3 in TNF-induced NF-kappaB activation. J Yang Y Lin Z Guo J Cheng J Huang L Deng W Liao Z Chen Z Liu B Su, Nat Immunol 2001 2 620 624 10.1038/89769 11429546
37. TAK1 is recruited to the tumor necrosis factor-alpha (TNF-alpha) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-kappaB activation. M Blonska PB Shambharkar M Kobayashi D Zhang H Sakurai B Su X Lin, J Biol Chem 2005 280 43056 43063 10.1074/jbc.M507807200 16260783
38. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. CK Ea L Deng ZP Xia G Pineda ZJ Chen, Mol Cell 2006 22 245 257 10.1016/j.molcel.2006.03.026 16603398
39. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. H Hsu J Huang HB Shu V Baichwal DV Goeddel, Immunity 1996 4 387 396 10.1016/S1074-7613(00)80252-6 8612133
40. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. C Wang L Deng M Hong GR Akkaraju J Inoue ZJ Chen, Nature 2001 412 346 351 10.1038/35085597 11460167
41. Interleukin-1. E Stylianou J Saklatvala, Int J Biochem Cell Biol 1998 30 1075 1079 10.1016/S1357-2725(98)00081-8 9785472
42. Toll-like receptors (TLRs) and immune disorders. S Akashi-Takamura K Miyake, J Infect Chemother 2006 12 233 240 10.1007/s10156-006-0477-4 17109085
43. TLR signaling pathways. K Takeda S Akira, Semin Immunol 2004 16 3 9 10.1016/j.smim.2003.10.003 14751757
44. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. MU Martin H Wesche, Biochim Biophys Acta 2002 1592 265 280 10.1016/S0167-4889(02)00320-8 12421671
45. TIR domain-containing adaptors regulate TLR signaling pathways. M Yamamoto S Akira, Adv Exp Med Biol 2005 560 1 9 fulltext 15932015
46. Negative regulation of toll-like receptor-mediated signaling by Tollip. G Zhang S Ghosh, J Biol Chem 2002 277 7059 7065 10.1074/jbc.M109537200 11751856
47. Distinct molecular mechanism for initiating TRAF6 signalling. H Ye JR Arron B Lamothe M Cirilli T Kobayashi NK Shevde D Segal OK Dzivenu M Vologodskaia M Yim,, et al. Nature 2002 418 443 447 10.1038/nature00888 12140561
48. Regulation of IRAK-4 kinase activity via autophosphorylation within its activation loop. H Cheng T Addona H Keshishian E Dahlstrand C Lu M Dorsch Z Li A Wang TD Ocain P Li,, et al. Biochem Biophys Res Commun 2007 352 609 616 10.1016/j.bbrc.2006.11.068 17141195
49. Mutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptor-associated kinase. X Li M Commane C Burns K Vithalani Z Cao GR Stark, Mol Cell Biol 1999 19 4643 4652 10373513
50. Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Z Jiang J Ninomiya-Tsuji Y Qian K Matsumoto X Li, Mol Cell Biol 2002 22 7158 7167 10.1128/MCB.22.20.7158-7167.2002 12242293
51. The coiled-coil domain of TRAF6 is essential for its auto-ubiquitination. K Yang J Zhu S Sun Y Tang B Zhang L Diao C Wang, Biochem Biophys Res Commun 2004 324 432 439 10.1016/j.bbrc.2004.09.070 15465037
52. Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation. B Lamothe A Besse AD Campos WK Webster H Wu BG Darnay, J Biol Chem 2007 282 4102 4112 10.1074/jbc.M609503200 17135271
53. Essential function for the kinase TAK1 in innate and adaptive immune responses. S Sato H Sanjo K Takeda J Ninomiya-Tsuji M Yamamoto T Kawai K Matsumoto O Takeuchi S Akira, Nat Immunol 2005 6 1087 1095 10.1038/ni1255 16186825
54. IRAK1: a critical signaling mediator of innate immunity. S Gottipati NL Rao WP Fung-Leung, Cell Signal 2008 20 269 276 10.1016/j.cellsig.2007.08.009 17890055
55. Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. JA Thomas JL Allen M Tsen T Dubnicoff J Danao XC Liao Z Cao SA Wasserman, J Immunol 1999 163 978 984 10395695
56. TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. H Wu JR Arron, Bioessays 2003 25 1096 1105 10.1002/bies.10352 14579250
57. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. MA Lomaga WC Yeh I Sarosi GS Duncan C Furlonger A Ho S Morony C Capparelli G Van S Kaufman,, et al. Genes Dev 1999 13 1015 1024 10.1101/gad.13.8.1015 10215628
58. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. A Naito S Azuma S Tanaka T Miyazaki S Takaki K Takatsu K Nakao K Nakamura M Katsuki T Yamamoto J Inoue, Genes Cells 1999 4 353 362 10.1046/j.1365-2443.1999.00265.x 10421844
59. Activation of p38, ERK1/2 and NIK pathways is required for IL-1beta and TNF-alpha-induced chemokine expression in human retinal pigment epithelial cells. ZM Bian SG Elner A Yoshida SL Kunkel J Su VM Elner, Exp Eye Res 2001 73 111 121 10.1006/exer.2001.1019 11428868
60. TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor. H Nakano H Oshima W Chung L Williams-Abbott CF Ware H Yagita K Okumura, J Biol Chem 1996 271 14661 14664 10.1074/jbc.271.25.14661 8663299
61. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase. R Shinkura K Kitada F Matsuda K Tashiro K Ikuta M Suzuki K Kogishi T Serikawa T Honjo, Nat Genet 1999 22 74 77 10.1038/8780 10319865
62. A20: central gatekeeper in inflammation and immunity. B Coornaert I Carpentier R Beyaert, J Biol Chem 2009 284 8217 8221 10.1074/jbc.R800032200 19008218
63. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. AW Opipari Jr HM Hu R Yabkowitz VM Dixit, J Biol Chem 1992 267 12424 12427 1618749
64. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. EG Lee DL Boone S Chai SL Libby M Chien JP Lodolce A Ma, Science 2000 289 2350 2354 10.1126/science.289.5488.2350 11009421
65. Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. L Yin L Wu H Wesche CD Arthur JM White DV Goeddel RD Schreiber, Science 2001 291 2162 2165 10.1126/science.1058453 11251123
66. Mekk3 is essential for early embryonic cardiovascular development. J Yang M Boerm M McCarty C Bucana IJ Fidler Y Zhuang B Su, Nat Genet 2000 24 309 313 10.1038/73550 10700190
67. A comprehensive map of the toll-like receptor signaling network. K Oda H Kitano, Mol Syst Biol 2006 2 2006 0015 10.1038/msb4100057 16738560
68. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. S Frantz L Kobzik YD Kim R Fukazawa R Medzhitov RT Lee RA Kelly, J Clin Invest 1999 104 271 280 10.1172/JCI6709 10430608
69. Intracellular and extracellular roles of S100 proteins. R Donato, Microsc Res Tech 2003 60 540 551 10.1002/jemt.10296 12645002
70. S100 chemokines mediate bookmarking of premetastatic niches. S Rafii D Lyden, Nat Cell Biol 2006 8 1321 1323 10.1038/ncb1206-1321 17139281
71. Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion. A Moon HY Yong JI Song D Cukovic S Salagrama D Kaplan D Putt H Kim A Dombkowski HR Kim, Mol Cancer Res 2008 6 1544 1553 10.1158/1541-7786.MCR-08-0189 18922970
72. HMGB1: endogenous danger signaling. JR Klune R Dhupar J Cardinal TR Billiar A Tsung, Mol Med 2008 14 476 484 10.2119/2008-00034.Klune 18431461
73. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. JS Park D Svetkauskaite Q He JY Kim D Strassheim A Ishizaka E Abraham, J Biol Chem 2004 279 7370 7377 10.1074/jbc.M306793200 14660645
74. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. ME Bianchi AA Manfredi, Immunol Rev 2007 220 35 46 10.1111/j.1600-065X.2007.00574.x 17979838
75. Isolation and characterization of two novel A20-like proteins. PC Evans ER Taylor J Coadwell K Heyninck R Beyaert PJ Kilshaw, Biochem J 2001 357 617 623 10.1042/0264-6021:3570617 11463333
76. Rheumatoid arthritis association at 6q23. W Thomson A Barton X Ke S Eyre A Hinks J Bowes R Donn D Symmons S Hider IN Bruce,, et al. Nat Genet 2007 39 1431 1433 10.1038/ng.2007.32 17982455
77. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. SL Musone KE Taylor TT Lu J Nititham RC Ferreira W Ortmann N Shifrin MA Petri MI Kamboh S Manzi,, et al. Nat Genet 2008 40 1062 1064 10.1038/ng.202 19165919
78. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. WTCCC, Nature 2007 447 661 678 10.1038/nature05911 17554300
79. A proteasome inhibitor reduces concurrent, sequential, and long-term IL-1 beta- and TNF-alpha-induced ECAM expression and adhesion. NM Dagia DJ Goetz, Am J Physiol Cell Physiol 2003 285 813 822 12788693
80. Effect of selective proteasome inhibitors on TNF-induced activation of primary and transformed endothelial cells. TJ Kalogeris FS Laroux A Cockrell H Ichikawa N Okayama TJ Phifer JS Alexander MB Grisham, Am J Physiol 1999 276 856 864 10199816
81. Transient IkappaB kinase activity mediates temporal NF-kappaB dynamics in response to a wide range of tumor necrosis factor-alpha doses. R Cheong A Bergmann SL Werner J Regal A Hoffmann A Levchenko, J Biol Chem 2006 281 2945 2950 10.1074/jbc.M510085200 16321974
82. A systems biology approach to construct the gene regulatory network of systemic inflammation via microarray and databases mining. BS Chen SK Yang CY Lan YJ Chuang, BMC Med Genomics 2008 1 46 10.1186/1755-8794-1-46 18823570
83. On the attenuation and amplification of molecular noise in genetic regulatory networks. BS Chen YC Wang, BMC Bioinformatics 2006 7 52 10.1186/1471-2105-7-52 16457708